EBV specific T cells

BIOLOGICAL2 trials

Sponsors

Baylor College of Medicine

Conditions

Epstein-Barr Virus InfectionsLymphoma

Phase 1

Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts

CompletedNCT00058812

Baylor College of MedicineEpstein-Barr Virus Infections

Start: 1993-05-31End: 2014-07-31Updated: 2015-01-29

LMP2a-Specific Cytotoxic T-Lymphocytes, Lymphoma (ACDAL)

TerminatedNCT00082225

Baylor College of MedicineLymphoma

Start: 2003-10-31End: 2008-01-31Updated: 2017-02-07

Related Papers

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.

2011-03-31203 citations